Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer disease brains

View ORCID ProfileBrenna C Novotny, View ORCID ProfileMaria Victoria Fernandez, Ciyang Wang, John P Budde, Kristy Bergmann, Abdallah Eteleeb, Joseph Bradley, Carol Webster, Curtis Ebl, Joanne Norton, Jen Gentsch, View ORCID ProfileUmber Dube, Fengxian Wang, John C Morris, View ORCID ProfileRandall J Bateman, Richard J Perrin, Eric McDade, Chengjie Xiong, Jasmeer Chhatwal, Dominantly Inherited Alzheimer Network Study Group, Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Metabolomics Consortium, View ORCID ProfileAlison Goate, Martin Farlow, View ORCID ProfilePeter Schofield, Helena Chui, View ORCID ProfileCeleste M Karch, View ORCID ProfileBruno A Benitez, Carlos Cruchaga, Oscar Harari
doi: https://doi.org/10.1101/2021.11.04.21265941
Brenna C Novotny
1Department of Psychiatry, Washington University School of Medicine (WUSM), St. Louis, MO, USA
2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brenna C Novotny
Maria Victoria Fernandez
1Department of Psychiatry, Washington University School of Medicine (WUSM), St. Louis, MO, USA
2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Victoria Fernandez
Ciyang Wang
1Department of Psychiatry, Washington University School of Medicine (WUSM), St. Louis, MO, USA
2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA
4Division of Biology & Biomedical Sciences, Washington University in St. Louis, St. Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John P Budde
1Department of Psychiatry, Washington University School of Medicine (WUSM), St. Louis, MO, USA
2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristy Bergmann
1Department of Psychiatry, Washington University School of Medicine (WUSM), St. Louis, MO, USA
2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdallah Eteleeb
1Department of Psychiatry, Washington University School of Medicine (WUSM), St. Louis, MO, USA
2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Bradley
4Division of Biology & Biomedical Sciences, Washington University in St. Louis, St. Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carol Webster
1Department of Psychiatry, Washington University School of Medicine (WUSM), St. Louis, MO, USA
2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Curtis Ebl
1Department of Psychiatry, Washington University School of Medicine (WUSM), St. Louis, MO, USA
2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanne Norton
1Department of Psychiatry, Washington University School of Medicine (WUSM), St. Louis, MO, USA
2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jen Gentsch
1Department of Psychiatry, Washington University School of Medicine (WUSM), St. Louis, MO, USA
2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Umber Dube
1Department of Psychiatry, Washington University School of Medicine (WUSM), St. Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Umber Dube
Fengxian Wang
1Department of Psychiatry, Washington University School of Medicine (WUSM), St. Louis, MO, USA
2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John C Morris
2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
5The Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA
6Department of Neurology, Washington University School of Medicine, Saint Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Randall J Bateman
2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
5The Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA
6Department of Neurology, Washington University School of Medicine, Saint Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Randall J Bateman
Richard J Perrin
2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
5The Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA
6Department of Neurology, Washington University School of Medicine, Saint Louis, MO, USA
7Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric McDade
6Department of Neurology, Washington University School of Medicine, Saint Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chengjie Xiong
5The Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jasmeer Chhatwal
8Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alison Goate
11Icahn School of Medicine at Mount Sinai, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alison Goate
Martin Farlow
12Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Schofield
13Neuroscience Research Australia, Randwick, Sydney, NSW, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter Schofield
Helena Chui
14Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Celeste M Karch
1Department of Psychiatry, Washington University School of Medicine (WUSM), St. Louis, MO, USA
2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Celeste M Karch
Bruno A Benitez
1Department of Psychiatry, Washington University School of Medicine (WUSM), St. Louis, MO, USA
2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bruno A Benitez
Carlos Cruchaga
1Department of Psychiatry, Washington University School of Medicine (WUSM), St. Louis, MO, USA
2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA
5The Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oscar Harari
1Department of Psychiatry, Washington University School of Medicine (WUSM), St. Louis, MO, USA
2Hope Center for Neurological Disorders. Washington University School of Medicine, St. Louis, MO, USA
3NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA
5The Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: harario@wustl.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The identification of multiple genetic risk factors for Alzheimer Disease (AD) provides evidence to support that many pathways contribute to AD onset and progression. However, the metabolomic and lipidomic profiles in carriers of distinct genetic risk factors are not fully understood. The metabolome can provide a direct image of dysregulated pathways in the brain, including information on treatment targets. In this study, we interrogate the metabolomic and lipidomic signatures in the AD brain, including carriers of pathogenic variants in APP, PSEN1, and PSEN2 (autosomal dominant AD; ADAD), APOE ε4 and TREM2 risk variant carriers, and non-carrier sporadic AD (sAD). We generated metabolomic and lipidomic data from parietal cortical tissue from 366 participants with AD pathology and 26 cognitively unimpaired controls using the Metabolon global metabolomics platform. We identified 133 metabolites associated with disease status (FDR q-value<0.05). In sAD brains these include tryptophan betaine (b=-0.57) and N-acetylputrescine (b=-0.14). Metabolites associated with sAD and ADAD include ergothioneine (b=-0.21 and -0.26 respectively) and serotonin (b=-0.34 and -0.58, respectively). TREM2 and ADAD showed association with α-tocopherol (b=-0.12 and -0.12) and CDP-ethanolamine (b=-0.13 and -0.10). β-citrylglutamate levels are associated with sAD, ADAD, and TREM2 compared to controls (b=-0.15; -0.22; and -0.29, respectively). Additionally, we identified a signature of 16 metabolites that is significantly altered between genetic groups (sAD vs. control p = 1.05×10-7, ADAD vs. sAD p = 3.21×10-5) and is associated with Braak tau stage and disease duration. These data are available to the scientific community through a public web browser (http://ngi.pub/Metabolomics). Our findings were replicated in an independent cohort of 327 individuals.

Competing Interest Statement

CC receives research support from: Biogen, EISAI, Alector and Parabon. The funders of the study had no role in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. CC is a member of the advisory board of Vivid genetics, Halia Therapeutics and ADx Healthcare.

Funding Statement

This work was possible thanks to the following governmental grants from the National institute of Health: NIA R01AG057777, RO1AG057777-02S1, K99AG061281, P30AG066444, P01AGO26276, NINDS R01NS118146 (BAB), R01AG044546 (CC), P01AG003991 (CC, JCM), RF1AG053303 (CC), RF1AG058501 (CC), U01AG058922 (CC), and the Chan Zuckerberg Initiative (CZI). O.H. is an Archer Foundation Research Scientist. This work was supported by access to equipment made possible by the Hope Center for Neurological Disorders, the NeuroGenomics and Informatics Center (NGI: https://neurogenomics.wustl.edu/) and the Departments of Neurology and Psychiatry at Washington University School of Medicine.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB of Washington University School of Medicine in St. Louis gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵10 Data used in preparation of this article were generated by the Alzheimer’s Disease Metabolomics Consortium (ADMC). As such, the investigators within the ADMC provided data but did not participate in analysis or writing of this report. A complete listing of ADMC investigators can be found at: https://sites.duke.edu/adnimetab/team/

Data Availability

Metabolomics data from the Knight ADRC donors generated for this study are available at the NIAGADS and can be accessed at https://www.niagads.org/knight-adrc-collection. Data generated from the DIAN cohort can be requested at https://dian.wustl.edu/our-research/for-investigators/diantu-investigator-resources/dian-tu-biospecimen-request-form/. We have accessed data from the ADNI (https://adni.loni.usc.edu, accessed 18 December, 2020), and ROSMAP (https://synapse.org/#!Synapse:syn26007829, accessed 18 December, 2020 and https://synapse.org/#!Synapse:syn26007830, accessed 30 July, 2021). Additional phenotypic data for the ROSMAP studies is available through the Rush AD Center Resource Sharing Hub (https://www.radc.rush.edu).

https://www.niagads.org/knight-adrc-collection

https://adni.loni.usc.edu

https://synapse.org/#!Synapse:syn26007829

https://synapse.org/#!Synapse:syn26007830

https://www.radc.rush.edu

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 30, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer disease brains
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer disease brains
Brenna C Novotny, Maria Victoria Fernandez, Ciyang Wang, John P Budde, Kristy Bergmann, Abdallah Eteleeb, Joseph Bradley, Carol Webster, Curtis Ebl, Joanne Norton, Jen Gentsch, Umber Dube, Fengxian Wang, John C Morris, Randall J Bateman, Richard J Perrin, Eric McDade, Chengjie Xiong, Jasmeer Chhatwal, Dominantly Inherited Alzheimer Network Study Group, Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Metabolomics Consortium, Alison Goate, Martin Farlow, Peter Schofield, Helena Chui, Celeste M Karch, Bruno A Benitez, Carlos Cruchaga, Oscar Harari
medRxiv 2021.11.04.21265941; doi: https://doi.org/10.1101/2021.11.04.21265941
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer disease brains
Brenna C Novotny, Maria Victoria Fernandez, Ciyang Wang, John P Budde, Kristy Bergmann, Abdallah Eteleeb, Joseph Bradley, Carol Webster, Curtis Ebl, Joanne Norton, Jen Gentsch, Umber Dube, Fengxian Wang, John C Morris, Randall J Bateman, Richard J Perrin, Eric McDade, Chengjie Xiong, Jasmeer Chhatwal, Dominantly Inherited Alzheimer Network Study Group, Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Metabolomics Consortium, Alison Goate, Martin Farlow, Peter Schofield, Helena Chui, Celeste M Karch, Bruno A Benitez, Carlos Cruchaga, Oscar Harari
medRxiv 2021.11.04.21265941; doi: https://doi.org/10.1101/2021.11.04.21265941

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (135)
  • Cardiovascular Medicine (1749)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (654)
  • Epidemiology (10785)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2935)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1919)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12501)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (322)
  • Neurology (2785)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (556)
  • Occupational and Environmental Health (597)
  • Oncology (1458)
  • Ophthalmology (441)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (334)
  • Psychiatry and Clinical Psychology (2633)
  • Public and Global Health (5342)
  • Radiology and Imaging (1004)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (724)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)